
Jordan Feld, MD, MPH, explains how HBsAg testing, NUC therapy, and monitoring capacity will shape access to hepatitis B functional cure.

Jordan Feld, MD, MPH, is the interim director of the Toronto Centre for Liver Disease at Toronto General Hospital, a professor of medicine, and holds the R. Phelan Chair in Translational Liver Research at the University of Toronto.

Jordan Feld, MD, MPH, explains how HBsAg testing, NUC therapy, and monitoring capacity will shape access to hepatitis B functional cure.